companydata.dkcompanydata.dk

NOVO NORDISK PHARMACEUTICALS A/S: Financial statements 2015

CVR: 24257924

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

NOVO NORDISK PHARMACEUTICALS A/S (CVR 24257924) has filed annual accounts for 2015. In 2015, the company reported a net result of DKK 1,879,000 compared with DKK 3,150,000 the year before. Equity in the 2015 report amounted to DKK 14,422,000. The solvency ratio was 99.9%.

Profit/Loss
DKK 1,879,000
Equity
DKK 14,422,000
Total Assets
DKK 14,442,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015--1.9M14.4M-
2014--3.2M12.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is NOVO NORDISK PHARMACEUTICALS A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

Lars Fruergaard Jørgensen joins the board of NOVO NORDISK PHARMACEUTICALS A/SApr 30, 2015

As of April 30, 2015, Lars Fruergaard Jørgensen has joined the board of directors of NOVO NORDISK PHARMACEUTICALS A/S.

Kåre Schultz leaves the board of NOVO NORDISK PHARMACEUTICALS A/SApr 30, 2015

As of April 30, 2015, Kåre Schultz has left the board of directors of NOVO NORDISK PHARMACEUTICALS A/S.

NOVO NORDISK PHARMACEUTICALS A/S: The 2014 annual report is outApr 27, 2015

NOVO NORDISK PHARMACEUTICALS A/S has published its annual report for 2014. The net result was DKK 3,150,000.

About NOVO NORDISK PHARMACEUTICALS A/S

NOVO NORDISK PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named NOVO FARMAKA A/S. The management consists of Anders Rytter Mikkelsen. The board consists of Naja Eilers Barrisøe (chair), Linette Tangsgaard Nielsen and Thomas Rask Nielsen. The company is owned by NOVO NORDISK A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -53,000 and a net result of DKK 2,074,000 compared with DKK 6,918,000 the year before. Equity in the 2025 report amounted to DKK 12,325,000.

Source: annual report 2025, Danish Business Authority